Burden of illness study in breast cancer

ASC Academics was commissioned by a prominent pharmaceutical client to conduct a comprehensive burden of illness study. The study aimed to quantify the impact of a specific disease on patients, caregivers, and society at large.

What we did

Project background

For the market access of their drug, a burden of illness and unmet need study was needed as part of a global value dossier.

Challenges faced

Because of the size of the search and the fact that it was part of a bigger project (GVD), it was a challenge to provide the information within the required timeframe and budget. It was especially challenging to refrain from postponing the tasks of the BOI study and prioritize other parts of this big project. Another difficulty was due to an already existing example of a similar project done prior to this one. The challenge was to keep thinking about how to put the information in this report and not just do the same as in the example.

Our solution

ASC Academics utilized a rigorous methodology to collect and analyze data from various sources, including clinical trials, medical records, patient surveys, and expert interviews. The team of experienced researchers and analysts employed their expertise to generate a robust description of the disease burden, including its prevalence, incidence, mortality, morbidity, and economic costs.

Our impact

ASC Academics' burden of illness research is characterized by its scientific rigour, methodological transparency, and practical relevance. The firm's deep domain knowledge, analytical expertise, and collaborative approach ensured that the insights were communicated effectively through a poster at the ESMO congress.